LNWWM
IMNM icon

Laird Norton Wetherby Wealth Management’s Immunome IMNM Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,881
Closed -$102K – 947
2022
Q1 		$102K Hold
17,881
– – 0.01% 899
2021
Q4 		$232K Hold
17,881
– – 0.01% 806
2021
Q3 		$435K Hold
17,881
– – 0.03% 552
2021
Q2 		$309K Buy
+17,881
New +$395K 0.02% 707

Other funds holding IMNM

PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's IMNM Position: Q2 2022 in Review

Laird Norton Wetherby Wealth Management sold out of Immunome (IMNM) in Q2 2022, closing a stake of 17,881 shares — an estimated $102K sold.

Laird Norton Wetherby Wealth Management first reported a position in IMNM in Q2 2021 and held it in 4 quarters. The position peaked at $435K in Q3 2021. 26 funds tracked by Wall St. Rank hold IMNM as of Q2 2022.

  • Laird Norton Wetherby Wealth Management reported no remaining Immunome position as of Q2 2022 after selling out during the quarter.
  • Laird Norton Wetherby Wealth Management sold 17,881 Immunome shares in Q2 2022, an estimated $102K.
  • Laird Norton Wetherby Wealth Management first reported a position in Immunome in Q2 2021 and held it in 4 quarters.
  • Laird Norton Wetherby Wealth Management's Immunome position peaked at $435K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Immunome as of Q2 2022.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q2 2022, filed 15 Aug 2022.